Structure–Activity Relationship Study on Ligands Activating the Voltage‐Gated Potassium Channel K V 7.1
Rattachement africain : de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
ABSTRACT K V 7.1 agonists are promising therapeutic agents for the treatment of hypertension, arrhythmia and preterm labor. The 3‐(indol‐3‐ylmethyl) substituted 1,4‐benzodiazepine (R)‐L3 has been reported as a potent K V 7.1 activator. In this study, (R)‐L3 was systematically modified at eight positions including the configuration at 3‐position. For the synthesis of the designed 1,4‐benzodiazepines 8 and 12 , 2‐aminobenzophenones 4 were reacted with amino acid derived 1,3‐oxazolidinediones 7 or 11 . The required 2‐aminobenzophenones 4 were obtained regioselectively by Sugasawa reaction of anilines 2 and 3 with various substituted benzonitriles, using BCl 3 and AlCl 3 . Racemization during deprotonation and alkylation of secondary lactams 8 and 12 was not observed. However, racemization occurred during conversion of lactam 8b into thiolactam 17 . The enantiomers of thiolactam rac ‐ 17 and triazole rac ‐ 18 were separated by chiral HPLC. The ion channel modulatory activity of the resulting 1,4‐benzodiazepines was evaluated by two‐electrode voltage‐clamp (TEVC) experiments. These TEVC experiments showed that (3 R )‐configuration and the indolylmethyl moiety at 3‐position are essential for K V 7.1 activation. High activity was observed for secondary lactam 8b and methylated lactam 9b , but larger N‐substituents reduced the channel activation. The thioamide ( R )‐ 17 and the triazole ( R )‐ 18 did not significantly activate the K V 7.1 channel. Replacement of the F‐atom in 2‐position of the 5‐phenyl moiety by a proton or other halogen atoms reduced the K V 7.1 activity. However, the 9‐hydroxy derivative 9i appeared to exhibit higher agonistic activity (+68% activity increase at 1 µM) than (R)‐L3 ( 9b , +45% at 1 µM). Moreover, higher phase I metabolic stability was observed for phenol 9i .
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- Structure–Activity Relationship Study on Ligands Activating the Voltage‐Gated Potassium Channel K <sub>V</sub> 7.1
- Date Crossref
- 01/06/2026
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Münster pays non établi dans la noticeUniversité ou école supérieure
-
University Hospital Münster Department of Cardiovascular Medicine pays non établi dans la noticeÉtablissement de santé
-
GRK 2515 pays non établi dans la noticeInstitution
University of Münster, Department of Cardiovascular Medicine — University Hospital Münster et GRK 2515.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.